Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)

Clinical trial NCT03253796 · COMPLETED

Trial details

NCT number: NCT03253796
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Spondyloarthritis

Start date: 2017-11-07
Primary completion: 2021-03-17
Enrollment: 323

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.